California’s latest effort at a drug price transparency bill, SB 17, moved one step closer to becoming law on Tuesday when it passed the State Senate 26-10. The legislation, sponsored by Sen. Ed Hernandez, would require the manufacturers of prescription drugs experiencing large increases in WAC to give purchasers 90 days’ advance notice of the increase, and report detailed information to the state Office of Statewide Health Planning and Development (OSHPD). Manufacturers of high cost new drugs would also be required to report a separate set of information to OSHPD. The OSHPD would publish reported information in a manner that permits identification on a per-drug basis.
SB 17 now goes to the Assembly. More detail on the legislation can be found here.